On the role of storage granules in the functional utilization of newly synthesized dopamine
- PMID: 1049242
- DOI: 10.1007/BF01248771
On the role of storage granules in the functional utilization of newly synthesized dopamine
Abstract
Previous studies have provided evidence for the prime importance of newly synthesized dopamine as compared with the large endogenous stores of amine in the functional mobilization of dopamine under conditions of a heavy demand on the neuron such as in the presence of a neuroleptic. The present study was designed to examine the role of storage granules in the utilization of newly synthesized dopamine and to examine the mechanism of the cataleptic action of reserpine-like drugs. It was found that the injection of a small dose of L-Dopa did not reverse the catalepsy produced by the short-acting dopamine depleter, Ro 4-1284, either when the depleter was given alone or was given after tyrosine hydroxylase blockade by alpha-methyltyrosine, provided that the L-Dopa was given at a time when Ro 4-1284 was present. However, the same dose of L-Dopa quickly reversed catalepsy when given at a time of dopamine depletion but in the absence of Ro 4-1284. Since alpha-methyltyrosine alone does not produce catalepsy until exhaustion of the large endogenous dopamine pool, but quickly potentiates neuroleptic-induced catalepsy, it is suggested that under normal conditions the slow transfer of stored dopamine to a releasable site is sufficiently rapid to maintain striatal function. However, the transfer rate appears to be too slow for adequate mobilization of the store under conditions of a heavy demand. It is further suggested that a prime role of storage granules is to channel newly synthesized dopamine into the synaptic cleft. Reserpine-like drugs appear to produce catalepsy, not by depletion per se of the main dopamine pool, but by interference with this granule channeling function.
Similar articles
-
On a prime role for newly synthesized dopamine in striatal function.Eur J Pharmacol. 1975 Feb;30(2):315-8. doi: 10.1016/0014-2999(75)90115-6. Eur J Pharmacol. 1975. PMID: 1168577
-
Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.Res Commun Chem Pathol Pharmacol. 1985 Apr;48(1):17-25. Res Commun Chem Pathol Pharmacol. 1985. PMID: 3873102
-
A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover.J Pharmacol Exp Ther. 1977 Dec;203(3):556-63. J Pharmacol Exp Ther. 1977. PMID: 21955 No abstract available.
-
Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.J Neurosci. 1998 Mar 15;18(6):1979-86. doi: 10.1523/JNEUROSCI.18-06-01979.1998. J Neurosci. 1998. PMID: 9482784 Free PMC article. Review.
-
Valbenazine.2023 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 37748010 Free Books & Documents. Review.
Cited by
-
Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.J Neural Transm. 1983;57(4):255-65. doi: 10.1007/BF01248997. J Neural Transm. 1983. PMID: 6140299
-
Proceedings of the British Pharmacological Society. Liverpool, 6th-8th April, 1988. Abstracts.Br J Pharmacol. 1988 Jul;94 Suppl(Suppl):312P-474P. Br J Pharmacol. 1988. PMID: 3382861 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials